Article

Are you trying to advance to key positions in the world of advertising, marketing, or high-tech? This is the degree that will build your next career step.

Picture of Sheet

Sheet

time: 4 min read

They say that today’s young people don’t know what they want – but the opposite is true. Quite a few 20-30 year olds have already set their career goals, and have conquered the first stage, and maybe the second. But there is one thing holding them back – one line missing from their resume: an academic degree. While many degrees are limited to a specific field of study, a business administration degree is different – because it provides knowledge and tools that allow graduates to integrate into almost any field, while advancing up the career ladder and developing a diverse and rewarding career.

“In the past, there was a misconception that business administration was a degree that you couldn’t do anything with, because it was too general,” says Dr. Mola Cohen, dean of the Faculty of Business Administration and Accounting at the Academic Center for Law and Business in Ramat Gan, which offers a bachelor’s degree in business administration. “But in recent years, they’ve realized that the opposite is true. Today, they’re no longer looking for people who can do just one thing, but rather those who have a broad education, who are able to develop and change, and adapt to different environments and the spirit of the times.

“A degree in business administration teaches everything you need to succeed in a business environment – that is, the foundation stones for every field of activity in the economy. In high-tech, marketing, communications, real estate, economics, finance – in each of these sectors, there is always a need for people with a degree in business administration who know how to locate and analyze data and trends, prepare business plans, advise and support management, and maximize human resources.”

“Graduates with a degree in business administration are integrated into a variety of key roles in today’s market – brand managers, digital campaign managers, planners in advertising companies, marketing and strategy managers, and the degree gives them the ability to advance to key positions in the company. For example, among the graduates of the track at the Academic Center, one can find the spokesperson for the global company Wolt in Israel, as well as a graduate who integrated into global high-tech companies – after working at Radware, he moved to the American company Gigmon, which operates in the field of information security, and today he manages its engineering activities.”

Learning from the field – and from the best

Dr. Molla Cohen emphasizes that the most important goal for him is to jumpstart students’ careers – among other things, through a meaningful connection to industry already during the degree. “With us, you don’t just learn from books and presentations, but also from the field, with a lot of practical experience in various fields,” says senior lecturer Dr. Michaela Elram, who holds a PhD from the Business School at Manchester Metropolitan University.

Dr. Michaela Elram, who worked for global companies such as Boots and Tesco and is currently a consultant to global companies and serves as a director at Rami Levy Marketing Shikma, researches and teaches at the Academic Center in the fields of global retailing, consumer decision-making, and more. According to her, “Our students are exposed to key people in various industries during their degree, and are already building a network for themselves that will allow them to integrate into any industry they want.”

Among the academic center’s collaborations in this degree are leading companies in their field – such as Rami Levy Shekma Marketing, the finance company Max, the real estate company Azorim, the media company Yifat Communications, and the BDO firm. “Each student who completes the degree also receives a professional certificate in their chosen field. Combined with the practical and theoretical knowledge they received, along with the acquaintance they acquired with senior figures in the economy – our students’ path to the most sought-after jobs, with the most rewarding salaries, is paved. The results on the ground indicate that they lead the salary charts in Israel,” says Elram.

The curriculum adapts itself to the student – not the other way around.

In the academic center’s approach, students do not have to stop their daily lives to study, but rather studies should be integrated into them naturally. “We have a combination of frontal learning and distance learning, with everything being very flexible and adaptable to the needs of each student. This flexibility allows them to continue working even while studying, with some already finding work in a company where they can develop their careers; it also allows us to benefit from students who come from all over the country, from Eilat to Kiryat Shmona,” emphasizes Cohen.

As part of that flexibility, students can start studying for their degree in the upcoming spring semester – instead of waiting until the beginning of the next academic year. “At most academic institutions, the start of studies for a degree is only in the fall semester, which begins after the Tishrei holidays,” says Elram. “For us, this is an unnecessary waste of time, and instead of having to wait almost a year, we allow students to start studying as soon as possible.”

The “student at the center” approach is also reflected in the admission requirements – no psychometric test required; and in the convenient payment options, including scholarships. “Each student receives close support from us, according to what he or she needs, including direct communication with the lecturers. The curriculum emphasizes a practical and goal-oriented path, and the quality of our teaching is among the leading in Israel. In terms of results, it works. Happily, more than 90% of the Academic Center’s students integrate into the labor market, in interesting positions and with high salary levels.”

Picture of Sheet

Sheet

Morbi art orci, malsuada sd fulviner in, dictum et risus. Elicum art volutpat. Nam eros lactus, tempor quis condimentum nec, viverra ac mi. Vivamus id ex sd quam agustas uimod a sit amet dolor. Morris elementum audio a niva conga socifit.

Picture of גיליון

גיליון

מורבי ארט אורצי, מאלסואדה סד פולווינר אין, דיקטום את ריסוס. אליקום ארט וולוטפט. נם ארוס לקטוס, טמפור קוויס קונדימנטום נק, ויווררה אק מי. ויוומוס איד אקס סד קואם אגסטס אוימוד א סיט אמט דולור. מוריס אלמנטום אודיו א ניבה קונגה סוסיפיט.

Sign up now

You will receive the latest news and updates about your favorite categories!

Related article

A team of Harvard researchers introduces TxAgent: an artificial intelligence agent for personalized care

 

TxAgent: A Breakthrough in Personalized Medical Care

The Zitnik Lab at Harvard University recently introduced TxAgent, an innovative artificial intelligence agent designed to revolutionize the therapeutic decision-making process. The development comes at a critical time as healthcare systems around the world seek ways to improve the efficiency of medical care and reduce medical errors.

Led by Prof. Marinka Zitnik, the team of researchers developed a system that combines advanced multi-step analysis and real-time dynamic access to huge medical databases. The system is able to assess complex drug interactions, identify potential contraindications, and suggest treatment strategies tailored to the specific patient based on their entire medical data.

“TxAgent represents a completely new approach to precision medicine,” explains Prof. Zitnik. “Instead of relying on standard protocols that are not always appropriate for every patient, our system analyzes each patient’s unique situation and offers a personalized treatment plan.”

TxAgent’s complex architecture integrates 211 different data analysis tools, ranging from traditional statistical models to advanced deep learning algorithms, all working in harmony to provide accurate and reliable treatment recommendations.

 

Advanced capabilities and technological innovation

One of TxAgent’s significant advantages is its ability to perform complex analyses of medical data in real time. The system can analyze a patient’s medical history, laboratory test results, genetic data, and information about previous treatments, and combine all of this with the latest scientific knowledge from global medical databases.

Unlike traditional clinical support systems, TxAgent goes beyond providing basic alerts, but offers in-depth, layered analysis:

  • Drug interaction analysis : The system identifies not only direct interactions between drugs, but also combined effects of several drugs together.
  • Genetic matching : TxAgent takes into account the patient’s genetic profile to predict drug efficacy and side effects.
  • Continuous learning : The system is constantly improving with each new case, updated in real time from new studies and clinical protocols.
  • Transparency in decision-making : Unlike “black box” systems, TxAgent provides clear explanations for each recommendation, which increases the medical team’s trust in the system.

Dr. James Chen, one of the senior researchers on the project, emphasizes: “One of the biggest challenges in medicine today is the enormous amount of information that doctors have to process. TxAgent helps filter the most relevant information and presents it clearly, allowing doctors to make more informed decisions in less time.”

 

The potential to improve treatment outcomes and patient safety

The clinical application of TxAgent holds significant potential for improving treatment outcomes and patient safety in several aspects:

  1. Reduce medical errors : According to studies, medication errors cause many unnecessary hospitalizations each year. TxAgent can reduce these errors by accurately identifying drug interactions and contraindications.
  2. Dose personalization : The system is able to recommend dosage adjustments based on many factors, including patient weight, kidney and liver function, medical history, and genetic profile.
  3. Improving treatment compliance : Through personalized recommendations, TxAgent can help reduce side effects and improve patients’ compliance with drug treatment.
  4. Streamlining decision-making processes : Making relevant information available in real time allows the medical team to make faster and more informed decisions.

In initial trials in a controlled clinical setting, TxAgent showed a 28% improvement in identifying potentially dangerous drug interactions, and a 34% improvement in tailoring treatment protocols to unique patient profiles.

 

Ethical challenges and questions

Despite the great promise, the development and implementation of systems like TxAgent also raises significant challenges:

  • Privacy and data security : The system requires access to sensitive medical information, which raises questions about data security and privacy.
  • Medical liability : Questions regarding liability in cases of error or system failure have not yet been fully resolved.
  • Integration into existing systems : Integrating the system into existing medical information systems poses a significant technical challenge.
  • Training of medical teams : The success of the system depends largely on the ability of medical teams to use it effectively.

Prof. Zitnik is aware of these challenges: “We take the ethical and practical questions seriously. TxAgent is intended to be a decision-support tool, not a substitute for medical judgment. The physician always remains the ultimate authority in the decision-making process.”

Summary: The Future of Personalized Medicine

TxAgent represents a significant step forward in the era of personalized medicine. The system demonstrates how artificial intelligence can be used as a powerful tool in the hands of medical staff, enabling more informed decisions tailored to the unique needs of each patient.

“Personalized medicine is not just a trend, but the future of medicine,” concludes Prof. Zitnik. “With tools like TxAgent, we are moving toward a world where medical care will be more precise, more efficient, and perfectly tailored to each patient.”

The research team is now planning larger clinical trials in collaboration with several hospitals across the United States, with the aim of testing the system’s effectiveness in a wide range of clinical scenarios and patient populations. If the trials are successful, TxAgent could be available to medical institutions within two to three years.

We tailor unique financing solutions for importers based on deep knowledge of the business.